HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ellen C Zwarthoff Selected Research

Leukemia

1/2012The leukemia-associated fusion protein MN1-TEL blocks TEL-specific recognition sequences.
2/2007The MN1 oncoprotein activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ellen C Zwarthoff Research Topics

Disease

37Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 12/2002
33Neoplasms (Cancer)
01/2022 - 01/2006
12Carcinoma (Carcinomatosis)
01/2021 - 01/2003
7Non-Muscle Invasive Bladder Neoplasms
01/2021 - 06/2010
3Hematuria
01/2017 - 11/2010
3Meningioma (Meningiomas)
07/2009 - 02/2007
2Carcinogenesis
05/2015 - 09/2005
2Melanoma (Melanoma, Malignant)
11/2014 - 08/2014
2Uveal melanoma
08/2014 - 06/2004
2Nevus (Nevi)
08/2014 - 08/2006
2Leukemia
01/2012 - 02/2007
2Thanatophoric Dysplasia (Dwarfism, Thanatophoric)
08/2006 - 12/2002
2Achondroplasia
08/2006 - 12/2002
1Disease Progression
05/2015
1Glioma (Gliomas)
11/2014
1Residual Neoplasm
08/2012
1Necrosis
01/2012
1Prostatic Neoplasms (Prostate Cancer)
05/2011
1Breast Neoplasms (Breast Cancer)
05/2010
1Colorectal Neoplasms (Colorectal Cancer)
01/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2008
1Pain (Aches)
05/2008
1Seborrheic Keratosis
08/2007
1Acanthosis Nigricans
08/2006
1Microsatellite Instability
01/2006
1Craniosynostoses (Craniosynostosis)
12/2002

Drug/Important Bio-Agent (IBA)

15Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
11/2020 - 12/2002
14Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2008
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2006
8Proteins (Proteins, Gene)FDA Link
12/2020 - 01/2006
4Biological ProductsIBA
01/2021 - 05/2015
4Phenobarbital (Luminal)FDA Link
10/2019 - 05/2010
4Telomerase (Telomerase Reverse Transcriptase)IBA
11/2014 - 02/2014
4Codon (Codons)IBA
01/2010 - 12/2002
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
2Peptides (Polypeptides)IBA
01/2019 - 08/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2019 - 10/2017
2Indicators and Reagents (Reagents)IBA
10/2016 - 11/2015
2ParaffinIBA
08/2014 - 05/2012
2Formaldehyde (Formol)FDA Link
08/2014 - 05/2012
2nuclear matrix protein 22IBA
07/2013 - 11/2010
2Phosphotransferases (Kinase)IBA
11/2009 - 04/2009
1Penfluridol (Semap)IBA
12/2020
1Transcription Factors (Transcription Factor)IBA
12/2020
1Chemokine ReceptorsIBA
12/2020
1ChemokinesIBA
12/2020
1PPAR gammaIBA
12/2020
1SolutionsIBA
10/2019
1Long Noncoding RNAIBA
10/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2018
1ClaudinsIBA
10/2017
1A-Form DNA (A-DNA)IBA
01/2017
1PlatinumIBA
07/2016
1CateninsIBA
05/2015
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
05/2015
1Cadherins (E-Cadherin)IBA
05/2015
1Interleukin-18 (Interleukin 18)IBA
01/2012
1InterleukinsIBA
01/2012
1LigandsIBA
01/2012
1Genetic Markers (Genetic Marker)IBA
01/2012
1CytokinesIBA
01/2012
1Matrix Metalloproteinases (MMPs)IBA
01/2012
1ErbB Receptors (EGF Receptor)IBA
01/2010
1Endothelins (Endothelin)IBA
11/2009
1Endothelin-1 (Endothelin 1)IBA
11/2009
11,25-dihydroxyvitamin DIBA
07/2009
1Oncogene Proteins (Oncogene Protein)IBA
10/2008
1cupric sulfide (CuS)IBA
05/2008
1Fibroblast Growth Factor 3IBA
08/2007
1Insulin-Like Growth Factor I (IGF-1)IBA
02/2007
1Insulin-Like Growth Factor II (Somatomedin A)IBA
02/2007
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2006
1Proto-Oncogene Proteins B-rafIBA
06/2004

Therapy/Procedure

9Therapeutics
12/2020 - 11/2009
6Cystectomy
01/2022 - 08/2012
3Neoadjuvant Therapy
01/2019 - 01/2017
3Drug Therapy (Chemotherapy)
07/2016 - 10/2008
2Nephroureterectomy
01/2021 - 01/2020
2Intravesical Administration
12/2020 - 01/2012
1Aftercare (After-Treatment)
09/2017
1Transurethral Resection of Bladder
01/2017
1Lymph Node Excision (Lymph Node Dissection)
01/2017
1Precision Medicine
04/2015
1Ligation
03/2012
1Immunotherapy
01/2012
1Conservative Treatment
05/2011
1Cystoscopes
05/2008
1Radiotherapy
04/2003